A chemically modular amino acid-based ionizable lipid platform advances intratracheal lipid nanoparticle-mediated delivery of RNA base editors to airway epithelia and corrects genetic mutation in cystic fibrosis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Musunuru, K. et al. N. Engl. J. Med. 392, 2235–2243 (2025).
Sun, Y. et al. Science 384, 1196–1202 (2024).
Qiu, M. et al. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).
Xue, Y. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02928-x (2025).
Gong, F. et al. Nat. Mater. https://doi.org/10.1038/s41563-026-02555-0 (2026).
Vlasova, K. Y. et al. Nat. Commun. 16, 4021 (2025).
Dong, Y. et al. Proc. Natl Acad. Sci. USA 111, 3955–3960 (2014).
Mall, M. A. et al. Nat. Rev. Dis. Primers 10, 53 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Y.D. is a co-founder and holds equity in Immunanoengineering Therapeutics. D.C. declares no competing interests.
Rights and permissions
About this article
Cite this article
Cao, D., Dong, Y. Delivering base editors to the lungs. Nat. Mater. (2026). https://doi.org/10.1038/s41563-026-02602-w
Published:
Version of record:
DOI: https://doi.org/10.1038/s41563-026-02602-w
